Bridgeway Capital Management’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $260K | Buy |
+61,901
| New | +$260K | 0.01% | 900 |
|
|
2024
Q1 | – | Sell |
-8,180
| Closed | -$89.6K | – | 1327 |
|
|
2023
Q4 | $89.6K | Hold |
8,180
| – | – | ﹤0.01% | 1256 |
|
|
2023
Q3 | $83.8K | Hold |
8,180
| – | – | ﹤0.01% | 1252 |
|
|
2023
Q2 | $129K | Sell |
8,180
-2,500
| -23% | -$39.5K | ﹤0.01% | 1216 |
|
|
2023
Q1 | $241K | Buy |
10,680
+1,630
| +18% | +$36.9K | 0.01% | 1068 |
|
|
2022
Q4 | $323K | Buy |
9,050
+1,667
| +23% | +$59.5K | 0.01% | 973 |
|
|
2022
Q3 | $288K | Buy |
+7,383
| New | +$288K | 0.01% | 1052 |
|